N
Natalia Rudovich
Researcher at Charité
Publications - 68
Citations - 2162
Natalia Rudovich is an academic researcher from Charité. The author has contributed to research in topics: Insulin & Adipose tissue. The author has an hindex of 22, co-authored 66 publications receiving 1735 citations. Previous affiliations of Natalia Rudovich include Free University of Berlin.
Papers
More filters
Journal ArticleDOI
Impact of cereal fibre on glucose-regulating factors
Martin O. Weickert,Matthias Möhlig,Corinna Koebnick,Jens J. Holst,Pawel Namsolleck,Michael Ristow,Martin A. Osterhoff,H. Rochlitz,Natalia Rudovich,Joachim Spranger,Andreas Pfeiffer +10 more
TL;DR: The consumption of highly purified insoluble dietary fibres accelerated the acute GIP and insulin response and was further associated with enhanced postprandial carbohydrate handling the following day upon ingestion of a control meal.
Journal ArticleDOI
Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance.
Ada L. Garcia,Bärbel Otto,Siegfried Reich,Martin O. Weickert,J. Steiniger,Anja Machowetz,Natalia Rudovich,Matthias Möhlig,N. Katz,M. Speth,F. Meuser,J. Doerfer,H. J. F. Zunft,Afh Pfeiffer,Corinna Koebnick +14 more
TL;DR: AX consumption improved postprandial metabolic responses after an LMCT in subjects with IGT and reduced total gh Relin response, suggesting that the acylated ghrelin-mediated orexigenic regulation is not improved as only total plasma ghrel in decreased.
Journal ArticleDOI
Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
Mariya Markova,Olga Pivovarova,Silke Hornemann,Stephanie Sucher,Turid Frahnow,Katrin Wegner,Juergen Machann,Klaus Juergen Petzke,Johannes Hierholzer,Ralf Lichtinghagen,Christian Herder,Maren Carstensen-Kirberg,Michael Roden,Natalia Rudovich,Susanne Klaus,Ralph Thomann,Rosemarie Schneeweiss,Sascha Rohn,Andreas Pfeiffer +18 more
TL;DR: D diets high in protein (either animal or plant) significantly reduced liver fat independently of body weight, and reduced markers of insulin resistance and hepatic necroinflammation in patients with type 2 diabetes.
Journal ArticleDOI
WISP1 Is a Novel Adipokine Linked to Inflammation in Obesity
V Murahovschi,Olga Pivovarova,Iryna Ilkavets,Renata M. Dmitrieva,S Döcke,Farnaz Keyhani-Nejad,Özlem Gögebakan,Martin A. Osterhoff,Margrit Kemper,Silke Hornemann,Mariya Markova,Nora Klöting,Martin Stockmann,Martin O. Weickert,V Lamounier-Zepter,Peter Neuhaus,Alexandra Konradi,Steven Dooley,Christian von Loeffelholz,Matthias Blüher,Andreas Pfeiffer,Natalia Rudovich +21 more
TL;DR: The data suggest that WISP1 may play a role in linking obesity to inflammation and insulin resistance and could be a novel therapeutic target for obesity.
Journal ArticleDOI
Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer’s disease?
TL;DR: Development of substrate-selective IDE modulators could overcome possible adverse effects of IDE modulator associated with multiplicity of IDE targets, and help overcome pathophysiological link between type 2 diabetes and Alzheimer’s disease.